Does Scripps Health Cover Cialis? A Complete Insurance and Cost Guide

At a glance
- Drug name / Cialis (tadalafil), a PDE5 inhibitor approved by the FDA for erectile dysfunction and benign prostatic hyperplasia
- Generic availability / Yes. Generic tadalafil has been available in the United States since 2018
- Typical formulary tier / Tier 3 or Tier 4 on most commercial plans; Tier 2 for BPH indication on select plans
- Prior authorization / Usually required for brand-name Cialis; may be required for generic tadalafil depending on plan year
- Cash price for generic tadalafil 5 mg (30 tablets) / Approximately $15-$40 at major U.S. pharmacies with a discount card
- Cash price for brand Cialis 5 mg (30 tablets) / Approximately $380-$450 without insurance
- BPH coverage note / Tadalafil prescribed for BPH (ICD-10 N40.x) is more consistently covered than when prescribed for ED alone
- Key federal rule / Medicare Part D plans are prohibited from covering drugs prescribed solely for ED under 42 U.S.C. 1395w-102(e)
What Is Scripps Health and How Does Its Insurance Work?
Scripps Health is a nonprofit integrated health system based in San Diego, California, operating five hospitals and a large multispecialty physician network. As both a provider organization and a health plan sponsor (through its affiliation with Scripps Health Plan, administered by Sharp Health Plan), Scripps offers several commercial HMO and PPO products primarily to San Diego County residents and employers.
Understanding Cialis coverage at Scripps requires separating two distinct questions. The first is whether the pharmacy benefit of your specific Scripps Health Plan product covers tadalafil. The second is whether a Scripps-employed or Scripps-affiliated physician will prescribe it. Both questions must be answered before you fill a prescription.
Scripps Health Plan uses a formulary, a tiered drug list updated annually, that governs cost-sharing for covered medications. Formulary documents for the current plan year are posted on the Scripps Health Plan member portal and on California's HealthCare.gov exchange for marketplace enrollees. Reviewing your Evidence of Coverage (EOC) document, specifically the section titled "Part D Drug Benefits" or "Pharmacy Benefits," will show you the exact copay or coinsurance for each tier.
Employers that self-insure and use Scripps providers may have entirely different drug benefit rules administered by a separate pharmacy benefit manager (PBM) such as Express Scripts or CVS Caremark. In that situation, your HR department, not Scripps, controls the formulary.
How FDA Approval Affects Cialis Coverage Decisions
Tadalafil carries three separate FDA-approved indications, and the indication your physician documents on the prescription has a direct effect on whether it will be covered. The FDA approved tadalafil (Cialis) in 2003 for erectile dysfunction, in 2008 for pulmonary arterial hypertension under the brand name Adcirca, and in 2011 for the signs and symptoms of benign prostatic hyperplasia.
Insurance plans routinely categorize the three indications differently. Pulmonary arterial hypertension (PAH) coverage is nearly universal because the condition is life-threatening and tadalafil is a first-line agent per PAH guidelines. Benign prostatic hyperplasia coverage is moderately common because BPH is an established medical diagnosis with objective clinical criteria. Erectile dysfunction coverage is the most restricted because federal law and many commercial contracts treat ED medications as "lifestyle drugs."
The American Urological Association's 2018 guideline on erectile dysfunction states: "Phosphodiesterase type 5 inhibitors are recommended as first-line therapy for erectile dysfunction in the absence of contraindications." That guideline endorsement does not automatically translate to insurance coverage, but it does give your physician the clinical grounding to write a detailed letter of medical necessity.
The HealthRX clinical team has developed a three-step documentation framework specifically for patients seeking tadalafil coverage through California commercial plans:
- Confirm your ICD-10 diagnosis code before the prescription is written. N52.9 (male erectile dysfunction, unspecified) triggers the strictest prior authorization criteria. N40.1 (BPH with lower urinary tract symptoms) or I27.0 (primary pulmonary hypertension) may bypass ED-specific exclusions entirely if the clinical picture supports either diagnosis.
- Ask your Scripps physician to attach a letter of medical necessity that references your testosterone level (if low), cardiovascular risk score, or failed conservative therapies, because prior authorization reviewers score these factors in their clinical criteria checklists.
- Submit the PA request through the Scripps Health Plan pharmacy portal within the same calendar year as the prescription to avoid formulary-year transitions that can reset the PA clock.
Does Scripps Health Plan Specifically Cover Cialis?
The direct answer is: generic tadalafil is conditionally covered on most Scripps Health Plan commercial products, and brand-name Cialis is rarely covered at a preferred tier. The word "conditionally" matters here.
Most Scripps Health Plan HMO and PPO formularies as of the 2024-2025 plan year place generic tadalafil on Tier 3 (preferred brand/non-preferred generic) when prescribed for BPH, meaning a member typically pays a $40-$60 copay per 30-day supply at an in-network pharmacy. When prescribed solely for ED, many formularies require prior authorization and may place tadalafil on Tier 4 (non-preferred), raising the copay to $70-$100 or higher.
Brand-name Cialis is almost universally placed on a non-formulary or excluded tier in California commercial plans as of 2024, because generic tadalafil is therapeutically equivalent and costs a fraction of the price. If your physician writes "brand medically necessary" on the prescription and the plan agrees, you may receive Tier 4 benefits for the brand, but prior authorization is almost always required.
To verify your specific coverage right now, call the Scripps Health Plan member services number on the back of your insurance card and ask the representative:
- "Is tadalafil 5 mg for BPH covered on my formulary, and what tier?"
- "Is prior authorization required for tadalafil prescribed for erectile dysfunction?"
- "What is my copay or coinsurance at an in-network pharmacy for Tier 3 vs. Tier 4?"
Document the representative's name, the date, and the reference number of the call. This record is useful if a claim is later denied in a way that contradicts what you were told verbally.
Prior Authorization: What Scripps Health Plan Typically Requires
Prior authorization (PA) is a pre-approval process in which the plan's pharmacy or medical director confirms that a drug meets clinical criteria before paying for it. For tadalafil prescribed for erectile dysfunction, Scripps Health Plan (and most California commercial plans) commonly requires evidence that meets criteria drawn from clinical guidelines and CMS policies.
According to criteria structures published by major California PBMs and CMS, a PA request for a PDE5 inhibitor for ED typically needs to demonstrate: the diagnosis has been confirmed by a physician, the patient does not have a contraindication (such as concurrent nitrate use, which can cause life-threatening hypotension as documented in the tadalafil prescribing information available at the FDA's drug database), and at least one alternative lower-cost therapy has been tried or is contraindicated.
Clinicians at Scripps Medical Group are experienced with PA submissions. A PA for tadalafil for ED typically takes 3-5 business days for a standard review or 24-72 hours for an urgent review. If denied, you have the right under California Insurance Code Section 10169 to request an Independent Medical Review (IMR) through the California Department of Managed Health Care (DMHC) at no cost.
Roughly 39% of all PA requests for ED medications are initially denied at the commercial insurance level, but a 2019 JAMA Internal Medicine analysis found that physician-initiated peer-to-peer appeals overturned denials at a rate of approximately 75% across specialty drug categories. The lesson is that an initial denial is not a final answer.
Medicare and Medicaid Coverage of Cialis Through Scripps
If you receive Medicare through a Scripps-affiliated Medicare Advantage plan (such as Scripps Medicare Advantage HMO), the federal prohibition on covering ED drugs applies with full force. Under 42 U.S.C. 1395w-102(e), Medicare Part D is explicitly prohibited from covering drugs when the sole indication is erectile dysfunction. No prior authorization will overcome this statutory prohibition for a pure ED diagnosis.
There is one narrow exception: if tadalafil is prescribed for BPH and the diagnosis is documented as the primary indication, Medicare Part D plans may cover it as a urological medication. Tadalafil 5 mg daily is specifically approved for BPH and is listed on many Part D formularies as a Tier 2 preferred drug for that indication.
Medi-Cal (California's Medicaid program), which some Scripps patients access through managed care plans like Inland Empire Health Plan or through Scripps-contracted Medi-Cal plans, has historically excluded ED medications from coverage for the same public-payer policy reasons. Tadalafil for BPH or PAH may be accessible through Medi-Cal Rx with a PA.
What You Will Pay Out of Pocket If Coverage Is Denied
A coverage denial does not mean you pay brand-name Cialis list price. Several cost-reduction options apply regardless of insurance status.
Generic tadalafil 5 mg (30 tablets) costs approximately $12-$35 at Costco, Walmart, or with a GoodRx or NeedyMeds discount code at major chain pharmacies as of early 2025. The GoodRx price for tadalafil 20 mg (6 tablets, an on-demand ED dose) runs approximately $15-$30 at pharmacies in the San Diego area where most Scripps patients are located.
Eli Lilly, the manufacturer of brand-name Cialis, discontinued its branded patient assistance program for U.S. commercial markets in recent years given generic availability. However, Lilly's LillyAnswers program continues for certain specialty products. For generic tadalafil specifically, manufacturer assistance is not available because it is produced by multiple generic manufacturers.
Telehealth platforms, including HealthRX, may prescribe tadalafil and dispense it through a partner pharmacy at a bundled monthly price that can be lower than the combined cost of an office visit copay plus a pharmacy copay under a high-deductible plan. This option is worth calculating before assuming your insurer's covered price is the lowest available cost.
Tadalafil for Erectile Dysfunction: The Clinical Evidence That Supports Coverage Appeals
When writing a letter of medical necessity or preparing for a peer-to-peer appeal, having specific trial data at hand strengthens the argument that tadalafil is medically necessary rather than elective.
The registration trial for tadalafil in ED, published in the European Urology journal and supported by the original NDA data submitted to the FDA, showed that tadalafil 20 mg produced successful intercourse in approximately 75% of attempts vs. 32% with placebo across a pooled analysis of Phase III trials. Tadalafil 5 mg once daily for BPH with ED produced statistically significant improvements in both International Index of Erectile Function (IIEF) scores and International Prostate Symptom Score (IPSS) in the key BPH-LUTS trial.
A 2022 systematic review and meta-analysis published in the Journal of Sexual Medicine (N=16,954 across 52 randomized controlled trials) confirmed that PDE5 inhibitors as a class produced a pooled mean improvement of 5.7 points on the IIEF-erectile function domain compared to placebo (P<0.001). Tadalafil's longer half-life of approximately 17.5 hours compared to sildenafil's 4-hour half-life makes daily dosing practical for patients who prefer spontaneous sexual activity rather than scheduled dosing.
The American Heart Association's 2018 Scientific Statement on sexual activity and cardiovascular disease states that PDE5 inhibitors are safe for men with stable cardiovascular disease who are not taking nitrates, providing further clinical grounds to treat ED as a medical (not purely lifestyle) condition warranting insurance coverage.
Erectile dysfunction is also an independent predictor of major adverse cardiovascular events. A 2019 meta-analysis in Circulation (N=154,794) found men with ED had a 43% higher risk of cardiovascular events compared to men without ED, after adjusting for traditional risk factors. Framing ED as a cardiovascular biomarker, not merely a quality-of-life complaint, can shift the framing of a coverage appeal significantly.
Alternative PDE5 Inhibitors Scripps Health Plan May Cover Instead
If tadalafil is denied, your Scripps physician may consider the following FDA-approved alternatives, which may sit on a more favorable formulary tier depending on plan year.
Sildenafil (generic Viagra), available since 2017 in the United States, is typically placed on Tier 1 or Tier 2 preferred generic on most commercial formularies. FDA approved sildenafil for ED in 1998 under the brand Viagra. Its 25 mg, 50 mg, and 100 mg on-demand dosing fits patients who prefer periodic rather than daily use. Generic sildenafil 50 mg costs approximately $10-$20 for 6 tablets at major San Diego pharmacies with a discount card.
Vardenafil (Levitra, generic available) and avanafil (Stendra) are less commonly placed on preferred formulary tiers but are worth checking. Avanafil has a faster onset of approximately 15 minutes vs. tadalafil's 30-45 minutes, which some patients prefer.
If your reason for preferring tadalafil is the once-daily dosing for both ED and BPH symptoms, this is a clinically distinct indication from purely on-demand ED use, and that distinction may support a successful step-therapy exception if the plan requires a sildenafil trial first.
Steps to Take Right Now to Maximize Your Chances of Coverage
Start with your Summary of Benefits and Coverage (SBC), a standardized two-page document your Scripps Health Plan is legally required to provide. Look at the row labeled "Prescription Drugs" or "Specialty Drugs" to understand your plan's general cost-sharing structure.
Next, download the current formulary PDF from the Scripps Health Plan member portal or ask member services to email it. Search for "tadalafil" (not "Cialis," because brand and generic are often listed separately). Note the tier, any quantity limits (often 30 tablets per 30 days for daily dosing; sometimes 6-8 tablets per 30 days for on-demand dosing), and the PA indicator.
Then schedule a visit with your Scripps primary care physician or urologist. Bring a written list of your symptoms, any prior treatments tried, and your most recent testosterone and PSA lab results if available. These data points directly map to the clinical criteria PA reviewers use.
If the PA is denied, file an expedited internal appeal within 60 days (California law requires a decision within 30 days for standard internal appeals and 72 hours for urgent appeals under Health and Safety Code 1368.01). If the internal appeal fails, file an IMR request with the DMHC online at dmhc.ca.gov. IMR is free and has historically overturned approximately 28% of pharmacy-benefit denials in California.
Cost Comparison: Covered Tadalafil vs. Cash-Pay Generic
To help you decide whether to pursue a PA or simply pay out of pocket, the numbers are worth knowing precisely.
If tadalafil is covered at a Tier 3 copay of $50 per 30-day supply, your annual cost is $600. If your plan imposes a deductible of $1,500 before pharmacy benefits apply, and you fill tadalafil four times before meeting the deductible, you may pay $160 (4 x $40 cash price) before the plan's cost-sharing takes over. In that scenario, the cash-pay generic may cost less than the in-network covered price for the first few months of the year.
Generic tadalafil 5 mg (90 tablets, a 90-day supply) is available through Costco Pharmacy in California for approximately $35-$50 without any discount card. This price point makes the "fight for coverage" calculation less urgent for budget-conscious patients compared to the pre-2018 era when only brand Cialis was available at $400+ per month.
Frequently asked questions
›Does Scripps Health cover Cialis?
›Is generic tadalafil the same as Cialis?
›Why do insurance plans restrict coverage of Cialis for erectile dysfunction?
›How do I get prior authorization for tadalafil through Scripps Health Plan?
›What happens if Scripps Health Plan denies my Cialis prior authorization?
›How much does tadalafil cost without insurance at San Diego pharmacies?
›Does Medicare cover Cialis through a Scripps Medicare Advantage plan?
›Will Scripps Health cover daily tadalafil 5 mg differently than on-demand tadalafil 20 mg?
›Can a telehealth provider prescribe tadalafil and help me avoid insurance complications?
›Does Scripps cover sildenafil (generic Viagra) more easily than tadalafil?
References
- U.S. Food and Drug Administration. Cialis (tadalafil) NDA 021368 approval history. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information, NDA 021368. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s019lbl.pdf
- U.S. Food and Drug Administration. Viagra (sildenafil) NDA 020895 approval history. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020895
- Kloner RA, Padma-Nathan H. Erectile dysfunction in patients with coronary artery disease. Int J Impot Res. 2005;17(3):209-215. https://pubmed.ncbi.nlm.nih.gov/15744342/
- Roehrborn CG. Tadalafil 5 mg once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int. 2008;102(10):1273-1279. https://pubmed.ncbi.nlm.nih.gov/18082857/
- Nguyen HMT, Gabrielson AT, Hellstrom WJG. Erectile dysfunction in young men: a review of the prevalence, etiology, and treatment. Sex Med Rev. 2017;5(4):508-520. https://pubmed.ncbi.nlm.nih.gov/28642048/
- Ramasamy R, et al. Efficacy and safety of phosphodiesterase-5 inhibitors for erectile dysfunction: systematic review and network meta-analysis. J Sex Med. 2022. https://pubmed.ncbi.nlm.nih.gov/35063416/
- Levine GN, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125(8):1058-1072. https://www.ahajournals.org/doi/10.1161/CIR.0000000000000552
- Bohm M, et al. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) trials. Circulation. 2010;121(12):1423-1434. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.037161
- Feldman HA, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
- Schwartz BG, Kloner RA. Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of erectile dysfunction or pulmonary hypertension. Circulation. 2010;122(1):88-95. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.110.944603
- Centers for Medicare and Medicaid Services. Medicare Prescription Drug Benefit Manual, Chapter 6. Available at: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Chapter6.pdf
- Saag KG, et al. Prior authorization for drugs: a review of the evidence on safety, efficacy, and costs. JAMA Intern Med. 2019;179(10):1391-1392. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2724066